These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8311561)

  • 1. Deterioration of renal function in a patient with lupus.
    Rankin EC; Nield GH; Isenberg DA
    Ann Rheum Dis; 1994 Jan; 53(1):67-71. PubMed ID: 8311561
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus nephritis.
    Daleboudt GM; Broadbent E; Berger SP; Kaptein AA
    Lupus; 2011 Mar; 20(3):290-8. PubMed ID: 21362752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lupus nephritis during pregnancy by renal biopsy.
    Krane NK; Thakur V; Wood H; Meleg-Smith S
    Am J Nephrol; 1995; 15(3):186-91. PubMed ID: 7618642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
    Jedlickova H; Bohmová J; Sirotkova A
    Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M; Saiz A; Fernández-Reyes MJ; Sánchez R; Zurita P; Urrego C
    Nefrologia; 2011; 31(2):231-3. PubMed ID: 21461001
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic lupus erythematosus: study of 48 patients with emphasis on renal involvement].
    Boas Mde L; Nakayama EE; Carvalho MF; Delfino Filho JF; Neiva SL; Habermann F; Franco RJ; Soares VA; de Almeida DB
    AMB Rev Assoc Med Bras; 1988; 34(5):165-74. PubMed ID: 3075059
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of cyclophosphamide bolus therapy in a girl with SLE with a nephritic onset].
    Ballati G; Tucciarone L; Diamanti A; Frangella E; Chiaramida N
    Minerva Pediatr; 1991 Sep; 43(9):573-6. PubMed ID: 1758394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide therapy of severe lupus nephritis.
    Appel GB
    Am J Kidney Dis; 1997 Dec; 30(6):872-6; discussion 876-8. PubMed ID: 9398136
    [No Abstract]   [Full Text] [Related]  

  • 11. Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients.
    Williams W; Bhagwandass A; Sargeant LA; Shah D
    Lupus; 2003; 12(8):640-5. PubMed ID: 12945726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do lupus glomerulonephritis and its treatment affect the renal reserve?
    Martinez-Bayona A; Musso CG; de la Hoz L; Tolosa RG; Torres HG; Martinez GA
    Int Urol Nephrol; 2019 Feb; 51(2):369-370. PubMed ID: 30515736
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of nephritis in systemic lupus erythematodes].
    Ligtenberg G; Derksen RH; Berden JH
    Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1941-4. PubMed ID: 8927179
    [No Abstract]   [Full Text] [Related]  

  • 14. [Invasive disseminated aspergillosis in combined immunosuppressive therapy in systemic lupus erythematosus].
    Teuber G; Schwarting A; Mildenberger P; Schmidt-Brücken G; Moll R; Bornemann A; Wandel E; Wanitschke R; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1996 Dec; 91(12):798-801. PubMed ID: 9082168
    [No Abstract]   [Full Text] [Related]  

  • 15. International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement.
    Doria A; Vitali C; Tincani A; Balestrieri G; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S31-8. PubMed ID: 9049451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus erythematosus.
    Martinelli R; Pereira LJ; Santos ES; Rocha H
    Nephron; 1996; 74(2):313-7. PubMed ID: 8893147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
    Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M
    Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An interactive national symposium with mentometer voting. Experienced specialists learned more about SLE with renal involvement].
    Jacobson SH; Ringertz B
    Lakartidningen; 1998 Dec; 95(50):5780-2. PubMed ID: 9889501
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
    Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U; Bauer H; Märker-Hermann E
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.